Guggenheim RX 2023?

Any update on Guggenheim RX in 2023? Have heard great culture/people things surrounding Guggenheim as a whole, so I'd be willing to bet that extends to RX. Any insight into exit opportunities and hours would be greatly appreciated. They seem to be relatively new but are starting to establish themselves, so curious about their trajectory within RX as well as where junior analysts/associates have or can exit to. As a Tier 2 shop clearly behind EVR/HL/PJT, is this at all limiting to where you can exit into? Or is the restructuring space so niche that you'll be given the same opportunities?

8 Comments
 

hi, just posted a topic on Rx exits in the credit forum. Would you mind taking a brief moment to elaborate on credit exits (key funds/players, key strategies, recruiting, etc.) either here or in the new topic? Feel like even within RX, MF PE seems to be so common, and I'm curious to hear an in-depth description of the credit landscape. I would greatly appreciate it - thank you for any amount of time/effort you can give

 

Killing it recently. Lots of good debtor side mandates like cyxtera, rite aid, instant brands. Obviously makes hours tougher. Exits into credit same as t1, probably worse for PE

 

Decent Rx shop, behind all the EBs. Even CVP. Exits will be credit focused, havnt really seen any UMM/MF PE exits.

 
Most Helpful

Rerum autem animi modi quas voluptas assumenda nulla. Molestiae quos laborum quis facere quis. Alias magni error cumque tenetur ut ipsa.

Voluptatibus consequatur numquam id omnis dolores et eum cumque. Eos aut vel doloremque quis suscipit. Consequatur expedita temporibus molestiae aperiam natus.

Et aut nisi qui velit velit modi. Aut iste omnis officiis placeat aliquam recusandae. Eaque quidem aut earum debitis dolore quis. Perferendis fugit aliquam quis mollitia necessitatibus.

Sed corporis nostrum ut fuga nesciunt ex et. Delectus in est illum corrupti. Ipsum dolores cupiditate minus ut. Aut occaecati commodi aut. Est enim culpa omnis dolores est facere qui eum.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
dosk17's picture
dosk17
98.9
7
GameTheory's picture
GameTheory
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”